| 7.55 0.99 (15.09%) | 11-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.44 |
1-year : | 11.03 |
| Resists | First : | 8.09 |
Second : | 9.44 |
| Pivot price | 6.89 |
|||
| Supports | First : | 7.02 |
Second : | 6.36 |
| MAs | MA(5) : | 6.84 |
MA(20) : | 6.82 |
| MA(100) : | 6.87 |
MA(250) : | 8.38  |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 28.4 |
D(3) : | 25.4 |
| RSI | RSI(14): 63.5 |
|||
| 52-week | High : | 12.6 | Low : | 5.8 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BVS ] has closed Bollinger Bands are 15.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.76 - 6.79 | 6.79 - 6.82 |
| Low: | 6.44 - 6.48 | 6.48 - 6.51 |
| Close: | 6.5 - 6.56 | 6.56 - 6.61 |
Tue, 04 Nov 2025
Bioventus: Q3 Earnings Snapshot - Stamford Advocate
Tue, 04 Nov 2025
Bioventus surges on Q3 beats (BVS:NASDAQ) - Seeking Alpha
Tue, 04 Nov 2025
Bioventus Inc. (BVS) Q3 FY2025 earnings call transcript - Yahoo Finance
Tue, 04 Nov 2025
Bioventus Reports Third Quarter Financial Results - TradingView
Tue, 04 Nov 2025
Bioventus Inc. SEC 10-Q Report - TradingView
Tue, 04 Nov 2025
Bioventus Reports Third Quarter Financial Results - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 67 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 11.7 (%) |
| Held by Institutions | 73.3 (%) |
| Shares Short | 1,910 (K) |
| Shares Short P.Month | 1,930 (K) |
| EPS | 0.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.41 |
| Profit Margin | 0.3 % |
| Operating Margin | 12.4 % |
| Return on Assets (ttm) | 3.6 % |
| Return on Equity (ttm) | 1.3 % |
| Qtrly Rev. Growth | -2.5 % |
| Gross Profit (p.s.) | 5.7 |
| Sales Per Share | 8.43 |
| EBITDA (p.s.) | 0.92 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 36 (M) |
| Levered Free Cash Flow | 19 (M) |
| PE Ratio | 251.66 |
| PEG Ratio | 0 |
| Price to Book value | 3.13 |
| Price to Sales | 0.89 |
| Price to Cash Flow | 13.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|